New drugs, procedures, and devices for hypertension

S Laurent, M Schlaich, M Esler - The Lancet, 2012 - thelancet.com
Successful treatment of hypertension is difficult despite the availability of several classes of
antihypertensive drug, and the value of strategies to combat the effect of adverse lifestyle …

Novel therapeutic targets for the treatment of heart failure

J Tamargo, J Lopez-Sendon - Nature reviews Drug discovery, 2011 - nature.com
Despite considerable therapeutic advances, heart failure remains a medical and
socioeconomic problem. Thus, there is a compelling need for new drugs that could improve …

Novel therapeutic targets for hypertension

L Paulis, T Unger - Nature Reviews Cardiology, 2010 - nature.com
Despite the existence of established, effective therapies for hypertension, new methods of
blood pressure and cardiovascular risk reduction are still needed. Novel approaches are …

Therapeutic perspectives in hypertension: novel means for renin–angiotensin–aldosterone system modulation and emerging device-based approaches

T Unger, L Paulis, DA Sica - European heart journal, 2011 - academic.oup.com
The conventional antihypertensive therapies including renin–angiotensin–aldosterone
system antagonists (converting enzyme inhibitors, receptor blockers, renin inhibitors, and …

The (pro) renin receptor and its interaction partners

J Peters - Pflügers Archiv-European Journal of Physiology, 2017 - Springer
The prorenin receptor was originally discovered as a receptor that binds renin and prorenin,
thereby inducing pro-fibrotic intracellular signal cascades. These effects are partially …

The (pro) renin receptor as a pharmacological target in cardiorenal diseases

H Funke-Kaiser, T Unger - Hypertension Research, 2023 - nature.com
Abstract The (pro) renin receptor ((P) RR) is not only a member of the renin-angiotensin
system (RAS) but also exerts several RAS-independent functions due to its multiple signal …

(Pro) renin receptors and angiotensin converting enzyme 2/angiotensin-(1-7)/Mas receptor axis in human aortic valve stenosis

T Peltonen, J Näpänkangas, P Ohtonen, J Aro… - Atherosclerosis, 2011 - Elsevier
BACKGROUND: There is increasing evidence that renin–angiotensin system (RAS) may
play a major role in the actively regulated fibrocalcific process in aortic valve stenosis (AS) …

Cardiovascular and renal pathologic implications of prorenin, renin, and the (pro) renin receptor: promising young players from the old renin-angiotensin-aldosterone …

P Balakumar, G Jagadeesh - Journal of cardiovascular …, 2010 - journals.lww.com
The overactivation of the renin-angiotensin-aldosterone system accounts for many
cardiovascular and renal abnormalities. At several levels of its cascade, the renin …

New antihypertensive drugs under development

J Tamargo, J Duarte, LM Ruilope - Current medicinal chemistry, 2015 - ingentaconnect.com
Hypertension is the most common cardiovascular disease and remains the most prevalent
risk factor for cardiovascular diseases and a major cause of death worldwide. Despite the …

Novel regulators and drug targets of cardiac hypertrophy

P Finckenberg, E Mervaala - Journal of hypertension, 2010 - journals.lww.com
Cardiac hypertrophy is classically considered as an adaptive and compensatory response
enabling cardiomyocytes to increase their work output and thus cardiac function …